|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C12N 15/13 | (2006.01) |
| (11) | Number of the document | 2059536 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07840953.9 |
| Date of filing the European patent application | 2007-08-14 | |
| (97) | Date of publication of the European application | 2009-05-20 |
| (45) | Date of publication and mention of the grant of the patent | 2014-01-08 |
| (46) | Date of publication of the claims translation | 2014-06-25 |
| (86) | Number | PCT/US2007/075932 |
| Date | 2007-08-14 |
| (87) | Number | WO 2008/022152 |
| Date | 2008-02-21 |
| (30) | Number | Date | Country code |
| 822362 P | 2006-08-14 | US |
| (72) |
BERNETT, Matthew J., US
CHU, Seung Yup, US
DESJARLAIS, John R., US
KARKI, Sher Bahadur, US
LAZAR, Gregory Alan, US
PONG, Erik WeiKing, US
RICHARDS, John O., US
ZHUKOVSKY, Eugene Alexander, US
|
| (73) |
Xencor, Inc.,
111 W. Lemon Avenue, Monrovia, CA 91016,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Optimizuoti antikūnai, kurių taikinys CD19 |
| OPTIMIZED ANTIBODIES THAT TARGET CD19 |
| Payment date | Validity (years) | Amount | |
| 2025-07-21 | 19 | 347.00 EUR |
| 2026-08-14 |